Clarus Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Rhea-AI Summary

Clarus Therapeutics Holdings announced its participation in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 20, 2021, at 2:05 p.m. ET. The virtual presentation will be accessible via the Investors section of its website, with an archived version available for 90 days post-event. Clarus focuses on advancing androgen and metabolic therapies for both men and women, and its first product, JATENZO®, targets unmet medical needs. For further details, visit Clarus Therapeutics’ official website.

NORTHBROOK, Ill., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it will present virtually at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, Monday, September 20, 2021, 2:05 p.m. ET.

The presentation will be webcast live and can be accessed through the Investors section of Clarus Therapeutics’ website at Investors.ClarusTherapeutics.com. An archived version of the webcast will be available approximately two hours following the live presentation for 90 days.

About Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. Clarus Therapeutics’ first commercial product is JATENZO®. For more information, visit www.clarustherapeutics.com and www.jatenzo.com. Follow us on Twitter (@Clarus_Thera) and LinkedIn (Clarus Therapeutics).

Clarus Investor Relations Contact:
Kara Stancell
kstancell@clarustherapeutics.com
(847) 562-4300 x 206

FAQ

When is Clarus Therapeutics presenting at the Oppenheimer Summit?

Clarus Therapeutics will present on September 20, 2021, at 2:05 p.m. ET.

How can I access the Clarus Therapeutics presentation?

The presentation can be accessed live through the Investors section of Clarus Therapeutics' website.

Will there be a recording of the Clarus Therapeutics presentation available?

Yes, an archived version will be available approximately two hours after the live presentation for 90 days.

What is the focus of Clarus Therapeutics?

Clarus Therapeutics specializes in developing androgen and metabolic therapies for men and women.

What is JATENZO® from Clarus Therapeutics?

JATENZO® is Clarus Therapeutics' first commercial product aimed at addressing unmet medical needs.